Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Form S-1 Chardan NexTech Acquisit
-
Passage Bio Inc. (PASG) PT Raised to $45 at Chardan Capital Markets
-
5 Penny Stocks To Watch This Week As Biotech Takes Spotlight
-
Form S-1 CHARDAN NEXTECH ACQUISIT
-
Quantum FinTech Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing March 10, 2021
-
Quantum FinTech Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing March 10, 2021
-
Chardan Capital Markets Upgrades Seres Therapeutics (MCRB) to Buy
-
Form 10-K Chardan Healthcare Acqui For: Dec 31
-
Taysha Gene Therapies (TSHA) PT Raised to $60 at Chardan Capital Markets
-
Senda Biosciences to virtually present at the Chardan 3rd Annual Microbiome Medicines Summit
-
4D Pharma to Present at Upcoming Investor Conferences in March
-
Vedanta Biosciences to Present at Upcoming Investor Conferences
-
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
Enterin to Present at Chardan's Virtual 3rd Annual Microbiome Medicines Summit
-
Kaleido Biosciences to Present at Chardan’s 3rd Annual Microbiome Medicines Summit
-
Kaleido Biosciences to Present at Chardan’s 3rd Annual Microbiome Medicines Summit
-
uniQure Announces 2020 Financial Results and Highlights Recent Company Progress
-
BiomX to Present at Upcoming March Investor Conferences
-
Emergent BioSolutions to Participate in Investor Conferences
-
Emergent BioSolutions to Participate in Investor Conferences
-
Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
-
Chardan Capital Markets Upgrades Emergent BioSolutions (EBS) to Buy on Sell-Off
-
Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
-
Lottery.com Enters into Definitive Agreement with Trident Acquisitions Corp. (TDAC) to Become Publicly Traded
-
Lottery.com, a Leading Platform to Play the Lottery Online, Enters into Definitive Agreement with Trident Acquisitions Corp. to Become Publicly Traded
-
Sensorion : A Chardan Top Pick for 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: PERISCOPE CAPITAL INC.
-
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
-
Quantum FinTech Acquisition Corporation Announces Exercise and Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Exercise and Closing of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
-
Editas Medicine (EDIT) PT Raised to $77 at Chardan Capital Markets
-
Intellia Therapeutics (NTLA) PT Raised to $85 at Chardan Capital Markets
-
Enterome Presenting at Upcoming Investor Meetings
-
Quantum FinTech Acquisition Corporation Announces Closing of $175 Million Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Closing of $175 Million Initial Public Offering
-
Pre-Open Stock Movers 02/09: (KALV) (HTBX) (GLUU) Higher; (BRPA) (INFI) (OCGN) Lower (more...)
-
Chardan Capital Markets Downgrades Ocugen, Inc. (OCGN) to Neutral Following Run-Up
-
IPO for SPAC Quantum FinTech Acquisition Corp (QFTA) Opens at $10.32
-
Quantum FinTech Acquisition Corp. (QFTA) Prices 17.5M Unit IPO at $10/Unit
-
Quantum FinTech Acquisition Corporation Announces Pricing of Upsized $175 Million Initial Public Offering
-
Quantum FinTech Acquisition Corporation Announces Pricing of Upsized $175 Million Initial Public Offering
-
Viveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing February 4, 2021
-
Viveon Health Acquisition Corp. Announces the Separate Trading of its Common Stock, Warrants and Rights Commencing February 4, 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: K2 PRINCIPAL FUND, L.P.
-
Natural Order Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants Commencing January 29, 2021
-
Natural Order Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants Commencing January 29, 2021
-
La Jolla Pharma (LJPC) PT Lowered to $15 at Chardan Capital Markets
-
Passage Bio (PASG) Prices 7M Share Common Offering at $22/Sh
-
Passage Bio Announces Pricing of Public Offering

